Open original FDA record ↗Recall record
- FDA identifier
- Z-0869-2021
- Company in FDA record
- The Magstim Company Limited
- FDA record creation date
- Jan 15, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
A small number of Neurosign 100 Intraoperative Nerve Monitors may have been dispatched without being configured appropriately for the supply mains within the target Country. The specific deficiency includes: 1. Onboard voltage selector set to 240V (European Standard), versus 120V requirement for the United States and Canada. 2. Fuses installed in the Power Entry Module (PEM) 2xT315mAL (240V Standard), versus the 2xT630mAL requirement for a 120V mains supply.
Source facts
- Action
- The firm initiated the recall by email on 12/08/2020. The letter explained the issue, requested the consignee examine the device to confirm that the voltage setting and the fuse ratings are correct.. Should there be a mismatch, the consignee is to discontinue use and notify Magstim Service Department at service@magstim.com or by telephone +44 (0) 199401241111. The firm will send a service pack for the instrument.
- Initiated
- 2020-12-08
- Root cause
- Process control
- Terminated
- 2023-02-16
- Distribution
- MN, NC, and NY
- Recall number
- Z-0869-2021
- Recall status
- Terminated
- CDRH record ID
- 185147
- FDA record created
- 2021-01-15
- Recall event number
- 87063